Sempra to supply LNG to Japan's JERA in 20-year contract-March 2024-www.financetom.com

Sempra to supply LNG to Japan's JERA in 20-year contract

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sempra to supply LNG to Japan's JERA in 20-year contract

Jul 31, 2025 5:32 AM

July 31 (Reuters) - Sempra Infrastructure, a unit of

utility Sempra ( SRE ), said on Thursday it has entered into a

20-year deal to supply 1.5 million tonnes per annum (Mtpa) of

liquefied natural gas (LNG) to Japan's JERA.

The LNG would be supplied from Sempra's ( SRE ) Port Arthur LNG

Phase 2 development project in Texas, it added.

Previous page： Abbott Says Health Canada Approves Dissolving Stent for Treating Blocked Arteries Below the Knee Next page： KALA BIO Says Will Cease Development of Drug Candidate, Eyes Layoffs After Failed Trial

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Abbott Says Health Canada Approves Dissolving Stent for Treating Blocked Arteries Below the Knee

Sep 29, 2025

08:52 AM EDT, 09/29/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) said Monday that Health Canada has approved the company's Esprit BTK Everolimus Eluting Resorbable Scaffold System for treating people with chronic limb-threatening ischemia below the knee. The system is designed to keep arteries open while delivering the drug everolimus to support vessel healing before completely dissolving, the company...

KALA BIO Says Will Cease Development of Drug Candidate, Eyes Layoffs After Failed Trial

Sep 29, 2025

08:51 AM EDT, 09/29/2025 (MT Newswires) -- KALA BIO ( KALA ) said Monday that it will cease development of its drug candidate KPI-012 as a potential treatment for persistent corneal epithelial defect after it failed to meet its primary endpoint of complete healing in a phase 2b clinical trial. KPI-012 also failed to achieve statistical significance for key secondary...

Novartis to Launch US Direct-to-Patient Platform for Cosentyx

Sep 29, 2025

08:50 AM EDT, 09/29/2025 (MT Newswires) -- Novartis ( NVS ) said Monday it plans to launch a direct-to-patient platform for Cosentyx in the US, effective Nov. 1. The company said the platform will give cash-paying patients the option to buy Cosentyx, a treatment for multiple immune-mediated inflammatory diseases, at a 55% discount off the list price. Novartis ( NVS...

Nigeria eyes certification of China's C919 jet for local airlines

Sep 29, 2025

* COMAC explores dry leasing support for Nigerian carriers * Nigeria aviation market growing with leasing access, lower fares * COMAC to display a plane at Nigeria's airshow, organisers say (Updates Sept. 28 story with fresh detail on air show, minister comment) By Allison Lampert and Lisa Barrington MONTREAL, Sept 28 (Reuters) - Nigeria's civil aviation authority is looking into...